Edo Richard

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi The Alzheimer myth and biomarker research in dementia
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Alzheimers Dis 31:S203-9. 2012
  2. ncbi Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI)
    Edo Richard
    Dept of Neurology, Academic Medical Centre, University of Amsterdam, The Netherlands
    J Neurol Sci 322:64-70. 2012
  3. ncbi Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects
    E Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Dement Geriatr Cogn Disord 33:204-9. 2012
  4. ncbi Patient satisfaction in neurological second opinions and tertiary referrals
    D Wijers
    Department of Neurology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
    J Neurol 257:1869-74. 2010
  5. ncbi Vascular risk factors and dementia--towards prevention strategies
    E Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Neth J Med 68:284-90. 2010
  6. ncbi Morphometric changes in the cortical microvascular network in Alzheimer's disease
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Alzheimers Dis 22:811-8. 2010
  7. ncbi Characteristics of dyshoric capillary cerebral amyloid angiopathy
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Neuropathol Exp Neurol 69:1158-67. 2010
  8. ncbi Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care
    E Richard
    Academic Medical Center, University of Amsterdam, Department of Neurology, Amsterdam, The Netherlands
    J Nutr Health Aging 14:315-7. 2010
  9. ncbi Vascular Care in Patients With Alzheimer Disease With Cerebrovascular Lesions Slows Progression of White Matter Lesions on MRI: The Evaluation of Vascular Care in Alzheimer's Disease (EVA) Study
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, Postbus 22660, 1100 DD, The Netherlands
    Stroke 41:554-6. 2010
  10. ncbi Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress
    Edo Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Alzheimer Dis Assoc Disord 23:198-204. 2009

Detail Information

Publications22

  1. ncbi The Alzheimer myth and biomarker research in dementia
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Alzheimers Dis 31:S203-9. 2012
    ..Acknowledging that dementia in old age is an essentially different condition from dementia at relatively younger age is needed and should lead to new approaches in dementia research...
  2. ncbi Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI)
    Edo Richard
    Dept of Neurology, Academic Medical Centre, University of Amsterdam, The Netherlands
    J Neurol Sci 322:64-70. 2012
    ..Founding of EDPI is an important first step in this direction...
  3. ncbi Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects
    E Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Dement Geriatr Cogn Disord 33:204-9. 2012
    ..Apathy may be associated with an increased risk of cognitive decline. The objective of this study was to investigate if apathy predicts the progression from MCI to Alzheimer's disease (AD)...
  4. ncbi Patient satisfaction in neurological second opinions and tertiary referrals
    D Wijers
    Department of Neurology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
    J Neurol 257:1869-74. 2010
    ..A day-care admission for neurological SO and TR leads to an increase of patient satisfaction, irrespective of making a new diagnosis or initiation of a new treatment...
  5. ncbi Vascular risk factors and dementia--towards prevention strategies
    E Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Neth J Med 68:284-90. 2010
    ..Major challenges for future studies are to select the optimal population, set the optimal treatment targets and select clinically relevant outcome parameters...
  6. ncbi Morphometric changes in the cortical microvascular network in Alzheimer's disease
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Alzheimers Dis 22:811-8. 2010
    ..Our data indicate that morphometric changes in the cortical capillary network occur in AD in a region-specific manner and may be related to cortical atrophy in the affected regions...
  7. ncbi Characteristics of dyshoric capillary cerebral amyloid angiopathy
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Neuropathol Exp Neurol 69:1158-67. 2010
    ..These results suggest that capCAA is pathologically and possibly pathogenetically distinct from larger vessel CAA, and that it is associated with a high APOE-ε4 allele frequency...
  8. ncbi Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care
    E Richard
    Academic Medical Center, University of Amsterdam, Department of Neurology, Amsterdam, The Netherlands
    J Nutr Health Aging 14:315-7. 2010
    ..Description of methodological issues in a trial designed to evaluate if a multi-component intervention aimed at vascular risk factors can prevent dementia...
  9. ncbi Vascular Care in Patients With Alzheimer Disease With Cerebrovascular Lesions Slows Progression of White Matter Lesions on MRI: The Evaluation of Vascular Care in Alzheimer's Disease (EVA) Study
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, Postbus 22660, 1100 DD, The Netherlands
    Stroke 41:554-6. 2010
    ..Treatment aimed at vascular risk factors in patients with early Alzheimer disease may be beneficial, possibly in an even earlier stage of the disease...
  10. ncbi Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress
    Edo Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Alzheimer Dis Assoc Disord 23:198-204. 2009
    ..Here, we report the outline of a pragmatic study that will attempt to answer this question and we describe the prevalence of cardiovascular risk factors in the target population...
  11. ncbi [Clinical applicability of the term 'transient neurological attack']
    E Richard
    Academisch Medisch Centrum Universiteit van Amsterdam, afd Neurologie, Meibergdreef 9, 1105 AZ Amsterdam
    Ned Tijdschr Geneeskd 152:1086-7. 2008
    ....
  12. ncbi Association of vascular factors with apathy in community-dwelling elderly individuals
    Suzanne A Ligthart
    Department of General Practice, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Arch Gen Psychiatry 69:636-42. 2012
    ..Apathy in community-dwelling elderly individuals has been associated with a history of stroke and other cardiovascular disease...
  13. ncbi Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review
    Suzanne A Ligthart
    Department of General Practice, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Vasc Health Risk Manag 6:775-85. 2010
    ..So far, few randomized controlled trials have focused on lowering the vascular risk profile to prevent or postpone cognitive decline or dementia...
  14. ncbi Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial
    Edo Richard
    Academic Medical Centre, University of Amsterdam, Postbus 22660, Amsterdam 1100DD, The Netherlands
    J Am Geriatr Soc 57:797-805. 2009
    ..To investigate whether vascular care slows dementia progression in patients with Alzheimer's disease with cerebrovascular lesions on neuroimaging...
  15. ncbi Cardiovascular risk management in community-dwelling elderly: opportunities for prevention
    Suzanne A Ligthart
    University of Amsterdam, Amsterdam, The Netherlands
    Eur J Prev Cardiol 19:1365-72. 2012
    ....
  16. ncbi Late-life depression, mild cognitive impairment, and dementia
    Edo Richard
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    JAMA Neurol 70:374-82. 2013
    ..To evaluate the association of late-life depression with mild cognitive impairment (MCI) and dementia in a multiethnic community cohort...
  17. ncbi Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?
    Hanneke Thoonsen
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Stroke 41:2690-2. 2010
    ..Here, we evaluate the literature on the risk of ICH as a complication in patients with AD treated with aspirin...
  18. ncbi [Limited benefit of diagnostic second opinions in a neurology department]
    Luuk Wieske
    Academisch Medisch Centrum, Amsterdam, afd Neurologie, The Netherlands
    Ned Tijdschr Geneeskd 155:A3542. 2011
    ..To describe the short and long term results of neurological second opinions with regard to medical aspects and patient satisfaction...
  19. ncbi Vascular risk factors as treatment target to prevent cognitive decline
    Edo Richard
    Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    J Alzheimers Dis 32:733-40. 2012
    ..In this review we discuss several pertinent methodological issues that need to be addressed to achieve an optimal design of new randomized controlled trials...
  20. ncbi Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
    Raoul P Kloppenborg
    Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
    J Neuroinflammation 7:18. 2010
    ..Immunosuppressive therapy appears to be an appropriate treatment for CAA encephalopathy...
  21. ncbi [Limited benefit of diagnostic second opinions in a neurology department]
    Luuk Wieske
    Academisch Medisch Centrum, Amsterdam, afd Neurologie, The Netherlands
    Ned Tijdschr Geneeskd 155:A3542. 2011
    ..To describe the short and long term results of neurological second opinions with regard to medical aspects and patient satisfaction...
  22. ncbi Cholinesterase inhibitors in dementia: yes, no, or maybe?
    Afina W Lemstra
    Academic Medical Centre, Department of Neurology, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    Age Ageing 36:625-7. 2007